*NeuroNexus
Type: Forecast
Overview
Description
NeuroNexus is a collaboratory of review groups within the Center for Devices and Radiological Health (CDRH), Center for Drug Evaluation and Research (CDER), and Center for Biologics Evaluation and Research (CBER) who review medical products used in the treatment, diagnosis, or management of neurological and psychiatric diseases and conditions. The NeuroNexus collaboratory formalizes a program to connect the 3 FDA centers with the following main objectives:
Expedite the development and review of novel therapies and diagnostics intended to treat, diagnose, or manage neurological and psychiatric disorders through shared knowledge, review efficiency, and cross-center communication.
Engage with other government, academic, clinical professional, patients, and industry partners to obtain up-to-date knowledge and activities on identified project areas.
Support congressionally mandated neuroscience programs, such as the Act for ALS, Neurology Drug Program, National Alzheimer's Prevention Act, etc.
Share and track information on neuroscience related activities within each center.
Est. Value
Min: $1,500,000
Max: $3,000,000
Max: $3,000,000
Est. Award Date
27-Jan
Future Opp
Source Est. Solicitation Date
26-Jul
Set Aside
To be determined
Place of Performance
USA
Forecast Source
Department of Health and Human Services
Center for Devices and Radiological Health is forecasted to issue a procurement for *NeuroNexus around 27-Jan worth up to $3,000,000.
Agency
Source Level 1 Agency
Department of Health and Human Services
Source Level 2 Agency
FDA
Source Level 3 Agency
Center for Devices and Radiological Health
Contacts
Potential Bidders and Partners
Similar Active Opportunities
Additional Detail
Date Published
11/6/26
Date Modified
11/7/26
Additional Notes
Program Office: 75F401; Contracting Office: 75F402